Evidence map›Paper›PMID 34772699›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2021

The Sympathetic Nervous System Modulates Cancer Vaccine Activity through Monocyte-Derived Cells.

Louis Hinkle, Yongbin Liu, Chaoyang Meng, Zhe Chen, Junhua Mai, Licheng Zhang, Yitian Xu, Ping-Ying Pan, Shu-Hsia Chen, Haifa Shen

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
0.3field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Louis HinkleDepartment of Nanomedicine, Houston Methodist Research Institute, Houston, TX.ORCID 0000-0002-1035-6444
Yongbin LiuDepartment of Nanomedicine, Houston Methodist Research Institute, Houston, TX.
Chaoyang MengDepartment of Nanomedicine, Houston Methodist Research Institute, Houston, TX.
Zhe ChenDepartment of Nanomedicine, Houston Methodist Research Institute, Houston, TX.ORCID 0000-0002-8324-2050
Junhua MaiDepartment of Nanomedicine, Houston Methodist Research Institute, Houston, TX.
Licheng ZhangCenter for Cancer Immunotherapy, Houston Methodist Research Institute, Houston, TX; and.ORCID 0000-0002-0632-014X
Yitian XuCenter for Cancer Immunotherapy, Houston Methodist Research Institute, Houston, TX; and.
Ping-Ying PanCenter for Cancer Immunotherapy, Houston Methodist Research Institute, Houston, TX; and.ORCID 0000-0002-2971-4221
Shu-Hsia ChenCenter for Cancer Immunotherapy, Houston Methodist Research Institute, Houston, TX; and hshen@houstonmethodist.org schen3@houstonmethodist.org.
Haifa ShenDepartment of Nanomedicine, Houston Methodist Research Institute, Houston, TX; hshen@houstonmethodist.org schen3@houstonmethodist.org.
Houston Methodist · USTexas A&M Health Science Center · US

Funding

Transport Oncophysics CoreU54CA210181 · NCI · METHODIST HOSPITAL RESEARCH INSTITUTE · PI WANG, RONGFU · 2016 to 2020
$9.3M
Mechanism of Intratumoral Transport of Particulate DrugsR01CA222959 · NCI · METHODIST HOSPITAL RESEARCH INSTITUTE · PI CHEN, SHU-HSIA, LIU, XUEWU · 2018 to 2023
$2.3M
LILRB modulates tumor microenvironment and promotes tumor progressionR01CA204191 · NCI · METHODIST HOSPITAL RESEARCH INSTITUTE · PI CHEN, SHU-HSIA · 2017 to 2022
$2.2M
Tumor vasculature-targeted nanotherapeutics for DNA damage responseR01CA193880 · NCI · METHODIST HOSPITAL RESEARCH INSTITUTE · PI SHEN, HAIFA · 2016 to 2020
$1.8M
NCI NIH HHS R01 CA193880NCI NIH HHS R01 CA204191NCI NIH HHS R01 CA222959NCI NIH HHS U54 CA210181
6 · The paper itself

Abstract

The sympathetic nervous system (SNS) is an important regulator of immune cell function during homeostasis and states of inflammation. Recently, the SNS has been found to bolster tumor growth and impair the development of antitumor immunity. However, it is unclear whether the SNS can modulate APC function. Here, we investigated the effects of SNS signaling in murine monocyte-derived macrophages (moMФ) and dendritic cells (DCs) and further combined the nonspecific β-blocker propranolol with a peptide cancer vaccine for the treatment of melanoma in mice. We report that norepinephrine treatment dramatically altered moMФ cytokine production, whereas DCs were unresponsive to norepinephrine and critically lack β

Indexed as

Cancer VaccinesMelanomaAnimalsCD8-Positive T-LymphocytesDendritic CellsMiceMonocytesNorepinephrinePropranololSympathetic Nervous SystemCancer VaccinesNorepinephrinePropranolol

Identifiers

PMID34772699
PMCPMC9583274
OpenAlexW3214079493

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.